# About Sermorelin Research: An Independent Editorial Digest

> Sermorelin Research is an independent editorial project that summarizes the peer-reviewed literature on sermorelin (GHRH(1-29)). Not a clinic, not a vendor, no medical advice.

An independent editorial board that reads the GHRH(1-29) literature straight and cites every figure to its source.

## What this site is

Sermorelin Research is an independent editorial project that publishes summaries of the peer-reviewed research literature on sermorelin (GHRH(1-29)). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "research" in our name is a position we occupy relative to the literature — the bench-research and analytical register, not a claim to run experiments, dispense anything, or offer treatment. We read studies and lay them out as a hard-edged evidence board: one figure, one cell, one source.

## How we handle the evidence

Every quantitative claim on this site is tied to a numbered citation in the [full reference list](/references), and we hold three lines firmly. We attribute drug-class findings to the molecule that actually produced them — body-composition and cognition data go to tesamorelin, bone-mineral data to the GHRP class, never silently to sermorelin. We state the regulatory history accurately: formerly FDA-approved for pediatric growth-hormone deficiency, withdrawn in 2008 for commercial reasons, now compounded as a Category 1 bulk substance under Section 503A. And we mark the gaps — where adult anti-aging and weight-loss evidence runs out, we say so rather than fill the space.

## What we do not do

We do not recommend doses for humans, describe protocols to follow, or frame any study figure as a personal instruction. We do not name product brands, list sellers, or quote prices. We do not claim a physical address, a phone line, or a clinical team. Where research-user communities report anecdotes, we label them as anecdote, not evidence. The site exists to make the published sermorelin record legible and verifiable — nothing more, and nothing for sale.

---

A forensic reading board for the GHRH(1-29) record — every endocrine figure, half-life, and metabolite logged to the study that measured it, the body-composition data filed where it belongs as tesamorelin, and the literature treated like an analyte read against a threshold: present and cited, or marked absent; no clinic behind the board and nothing here dosed, dispensed, or sold.